Table 1 Randomization factors by study arm, stratified by traditional risk groups.

From: Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial

 

High traditional risk (n = 505)

 

Low traditional risk (n = 519)

 

Intervention

Control

 

Intervention

Control

 

(n = 252)

(n = 253)

 

(n = 261)

(n = 258)a

Females N, (%)

131 (52.0%)

135 (53.4%)

 

130 (49.8%)

126 (48.8%)

Age group N, (%)

     

 18–44 years

108 (42.9%)

117 (46.3%)

 

133 (51.0%)

125 (48.5%)

 45–69 years

144 (57.1%)

136 (53.8%)

 

128 (49.0%)

133 (51.6%)

Age in years, mean, (SD)

48.2 (14.0)

47.9 (13.9)

 

46.0 (15.4)

45.5 (14.6)

State N, (%)

     

 NSW

87 (34.5%)

79 (31.2%)

 

59 (22.6%)

64 (24.8%)

 QLD

53 (21.0%)

65 (25.7%)

 

52 (19.9%)

40 (15.5%)

 WA

23 (9.1%)

22 (8.7%)

 

31 (11.9%)

30 (11.6%)

 NT

2 (0.8%)

3 (1.2%)

 

0 (0%)

1 (0.4%)

 TAS

8 (3.2%)

12 (4.7%)

 

14 (5.4%)

11 (4.3%)

 VIC

66 (26.2%)

62 (24.5%)

 

79 (30.3%)

86 (33.3%)

 SA

8 (3.2%)

6 (2.4%)

 

22 (8.4%)

20 (7.8%)

 ACT

5 (2.0%)

4 (1.6%)

 

4 (1.5%)

6 (2.3%)

  1. aExcluding one participant who withdrew all consent from the study.
Back to article page